Avalon GloboCare Corp

Research Avalon GloboCare Corp (ALBT) on Bullrun: market cap USD 1.82M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 1.82M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 0-USD 18.26M-USD 4.99Mn/a-5.64USD 109.09KUSD 940.36KUSD 9.23M
FY2024USD 1.33M-USD 7.90M-USD 4.96M20.1%-8.44USD 2.66MUSD 2.12MUSD 7.10M
FY2023USD 1.26M-USD 16.71M-USD 6.53M19.0%-23.8USD 285.40KUSD 1.00MUSD 7.37M
FY2022USD 1.20M-USD 11.93M-USD 7.04M22.7%-1.28USD 1.99MUSD 4.57MUSD 11.16M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-07-28USD 1.82Mn/an/an/a
20252025-12-31USD 5.10Mn/an/an/a
20242024-12-31USD 4.70Mn/an/an/a
20232023-12-29USD 5.31Mn/an/an/a
20222022-12-30USD 51.99Mn/an/an/a
20212021-12-31USD 72.53Mn/an/an/a

About Avalon GloboCare Corp

Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software.

Related stock research

Other Real Estate stocks

Frequently asked questions

What is Avalon GloboCare Corp's market cap?

Avalon GloboCare Corp's market capitalization is USD 1.82M.

What does Avalon GloboCare Corp do?

Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software.